Future gazing with Hannah Kuchler
Three hot IP issues for the pharmaceutical industry
Sale of Theramex by CVC to Carlyle and PAI Partners completes
by Emma Danks and Suzy Davis
Orphan drug protection: clarification needed
UK medicines – Is the Northern Ireland Protocol now unsustainable?
The UK and the Trans-Pacific Partnership – Could patent conflicts ruin the deal?
Available in English and Japanese
English patent torpedoes and the UPC
Advising Apollo Therapeutics on $145 million financing
by Andrew Edge and Chris Cowley
Compulsory licensing in Germany – the coronavirus crisis and beyond